Sl No Display All
61 P.C., Quan, A., Al-Omran, M., Lovren, F., Pan, Y., Brezden-Masley, C., Ingram, A.J., Stanford, W.L., Teoh, H., Verma, S., BRCA1 is a Novel Target to Improve Endothelial Dysfunction and Retard Atherosclerosis, Journal of Thoracic and Cardiovascular Surgery
62 Thompson, M.D., Mei, Y., Weisbrod, R.M., Silver, M., Shukla, P.C., Bolotina, V.M., Cohen, R.A., Tong, X, Glutathione adducts on sarcoplasmic/endoplasmic reticulum Ca2+ ATPase C674 regulate endothelial cell calcium stores and angiogenic function as well as
63 Loebel M, Holzhauser L, Hartwig JA, Shukla PC, Savvatis K, Jenke A, Skurk C. et.al,, The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis, European Heart Journal, 876-887, 2018
64 Bhattacharya A, Chowdhury A, Chaudhury K, Shukla PC., Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer, Biochim Biophys Acta Rev Cancer., 1876, 188581, 2021
65 Duddu S, Agrawal M, Chakrabarti R, Ghosh A, Chakravorty N, Tiwari A, Shukla PC., Meta-analysis reveals inhibition of the inflammatory cytokine IL-6 affords limited protection post-myocardial ischemia/infarction., Heliyon, 8(8), 2022
66 Mukherjee M, Rahaman M, Ray SK, Shukla PC, Dolai TK, Chakravorty N., Revisiting fetal hemoglobin inducers in beta-hemoglobinopathies: a review of natural products, conventional and combinatorial therapies, Mol Biol Rep, 2022
67 Rahaman M, Mukherjee M, Bhattacharya S, Mukherjee B, Shukla PC, Dolai TK, Chakravorty N., Exploring the crosstalk between long non-coding RNAs and microRNAs to unravel potential prognostic and therapeutic biomarkers in ?-thalassemia, Mol Biol Rep, 2022
68 Rituparna Chakrabarti, Sushmitha Duddu, Ashutosh Tiwari, K. Tejaswi Naidu, Pooja Sharma, Nishant Chakravorty, Praphulla Chandra Shukla, Natural Killer T cells and the invariant subset promote atherosclerosis: A meta-analysis, Life Sciences, 321, 121620, 2
69 Ashalatha Ganesh, Nishant Chakravorty, Rashmi Mukherjee, Sourendrakanta Goswami, Koel Chaudhury and Baidyanath Chakravarty, Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in
70 Chakravorty N., Ivanovski S. , Prasadam I. , Crawford R. , Oloyede A. , Xiao Y., The microRNA expression signature on modified titanium implant surfaces influences genetic mechanisms leading to osteogenic differentiation, Acta Biomaterialia, 2012
71 Nishant Chakravorty, Stephen Hamlet, Anjali Jaiprakash, Ross Crawford, Adekunle Oloyede, Mohammed Alfarsi, Yin Xiao and Saso Ivanovski, Pro-osteogenic topographical cues promote early activation of osteoprogenitor differentiation via enhanced TGF?, Wnt an
72 Baishakhi De, Koushik Bhandari, Nishant Chakravorty, Ranjan Mukherjee, Rohit Gundamaraju, Rajeev K Singla, Prakash Katakam, Shanta K Adiki, Biswajoy Ghosh, Analava Mitra, Computational pharmacokinetics and in vitro-in vivo correlation of anti-diabetic syn
73 Das S. S., James M. , Paul S. , Chakravorty N, miRnalyze: an interactive database linking tool to unlock intuitive microRNA regulation of cell signaling pathways, Database, 2017
74 Barik A., Banerjee S. , Dhara S. , Chakravorty N, A Reductionist Approach to Extract Robust Molecular Markers from Microarray Data Series -Isolating Markers to Track Osseointegration, Journal of Biomedical Informatics, 68, 104-111, 2017
75 Barik A., Banerjee S. , Dhara S. , Chakravorty N, A Reductionist Approach to Extract Robust Molecular Markers from Microarray Data Series -Isolating Markers to Track Osseointegration, Journal of Biomedical Informatics, 2017
76 Das S. ., Saha P. , Chakravorty N., miRwayDB: a database for experimentally validated microRNA-pathway associations in pathophysiological conditions, Database, 2018
77 Das S. S., Sinha R. , Chakravorty N., Integrative microRNA and gene expression analysis identifies new drug repurposing candidates for fetal hemoglobin induction in - hemoglobinopathies, Gene, 77-83, 2019
78 Das S. S., Chakravorty N, Identification of deleterious SNPs and their effects on BCL11A, the master regulator of fetal hemoglobin expression, Genomics, 2019
79 Das S. S., Mitra A. , Chakravorty N, Diseases and their clinical heterogeneity Are we ignoring the SNiPers and micRomaNAgers? An illustration using Beta-thalassemia clinical spectrum and fetal hemoglobin levels, Genomics, 111, 67-75, 2019
80 D. Sheet, H. Garud, A. Suveer, J. Chatterjee and M. Mahadevappa, Brightness Preserving Dynamic Fuzzy Histogram Equalization, IEEE Trans. on Consumer Electronics, 2010